Simvastatin protects bladder and renal functions following spinal cord injury in rats

Journal of Inflammation

Volumn 7, Issue , 2010, Pages

  Shunmugavel, Anandakumar ^a   Khan, Mushfiquddin ^a   Te Chou, Peter C ^a   Dhindsa, Ramanpreet K ^a   Martin, Marcus M ^b   Copay, Anne G ^b   Subach, Brian R ^b   Schuler, Thomas C ^b   Bilgen, Mehmet ^a   Orak, John K ^a   Singh, Inderjit ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b The Spinal Research Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; SIMVASTATIN;

ADULT ANIMAL; ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLADDER DISEASE; BLADDER FUNCTION; BLADDER HYPERTROPHY; BLADDER HYPETROPHY; CELL DEATH; CONTROLLED STUDY; DETRUSOR MUSCLE; DRUG ACTIVITY; EPITHELIUM HYPERPLASIA; FEMALE; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LAMINA PROPRIA; LOCOMOTION; MUSCLE HYPERTROPHY; NONHUMAN; OSMOLALITY; RAT; RENAL PROTECTION; SCORING SYSTEM; SPINAL CORD INJURY; STAINING; URINALYSIS;

ANIMALIA; RATTUS;

EID: 77950920915     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-7-17     Document Type: Article

References (64)

1. Central neural control of the lower urinary tract. WC de Groat, Ciba Found Symp 1990 151 27 44 2226064
2. Animal models of sacral neuromodulation for detrusor overactivity. JR Vignes M Deloire K Petry, Neurourol Urodyn 2009 28 8 12 10.1002/nau.20612 18785181
3. Transneuronal labeling of neurons in the adult rat brainstem and spinal cord after injection of pseudorabies virus into the urethra. MA Vizzard VL Erickson JP Card JR Roppolo WC de Groat, J Comp Neurol 1995 355 629 640 10.1002/cne.903550411 7636036
4. Coordination of the bladder detrusor and the external urethral sphincter in a rat model of spinal cord injury: effect of injury severity. V Pikov JR Wrathall, J Neurosci 2001 21 559 569 11160435
5. Studies of detrusor-sphincter synergia and dyssynergia during micturition in rats via fractional Brownian motion. S Chang ST Mao SJ Hu WC Lin CL Cheng, IEEE Trans Biomed Eng 2000 47 1066 1073 10.1109/10.855934 10943055
6. Involvement of STAT3 in bladder smooth muscle hypertrophy following bladder outlet obstruction. O Fujita M Asanuma T Yokoyama I Miyazaki N Ogawa H Kumon, Acta Med Okayama 2006 60 299 309 17189973
7. Basic fibroblast growth factor modulates proliferation and collagen expression in urinary bladder smooth muscle cells. M Imamura A Kanematsu S Yamamoto Y Kimura I Kanatani N Ito Y Tabata O Ogawa, Am J Physiol Renal Physiol 2007 293 1007 1017 10.1152/ajprenal.00107.2007 17634401
8. Deletion of one SERCA2 allele confers protection against bladder wall hypertrophy in a murine model of partial bladder outlet obstruction. J Lassmann J Sliwoski A Chang DA Canning SA Zderic, Am J Physiol Regul Integr Comp Physiol 2008 294 58 65 17977917
9. Changes of rat urinary bladder during acute phase of spinal cord injury. H Mimata F Satoh T Tanigawa Y Nomura J Ogata, Urol Int 1993 51 89 93 10.1159/000282520 8351761
10. Switches in cardiac muscle gene expression as a result of pressure and volume overload. K Schwartz KR Boheler D de la Bastie AM Lompre JJ Mercadier, Am J Physiol 1992 262 364 369 1532697
11. Validation of the weight-drop contusion model in rats: a comparative study of human spinal cord injury. GA Metz A Curt H van de Meent I Klusman ME Schwab V Dietz, J Neurotrauma 2000 17 1 17 10.1089/neu.2000.17.1 10674754
12. Transcutaneous electrical stimulation of urinary bladder in patients with spinal cord injuries. K Radziszewski H Zielinski P Radziszewski R Swiecicki, int urol Nephrol 2009 41 497 503 10.1007/s11255-008-9488-7 19003426
13. Uncontrollable stimulation undermines recovery after spinal cord injury. JW Grau SN Washburn MA Hook AR Ferguson ED Crown G Garcia KA Bolding RC Miranda, J Neurotrauma 2004 21 1795 1817 10.1089/neu.2004.21.1795 15684770
14. Therapy Insight: bladder dysfunction associated with multiple sclerosis. V Kalsi CJ Fowler, Nat Clin Pract Urol 2005 2 492 501 10.1038/ncpuro0323 16474623
15. Functional improvement in spinal cord injury-induced neurogenic bladder by bladder augmentation using bladder acellular matrix graft in the rat. S Urakami H Shiina H Enokida K Kawamoto N Kikuno T Fandel K Vejdani L Nunes M Igawa EA Tanagho R Dahiya, World J Urol 2007 25 207 213 10.1007/s00345-006-0142- 7 17221271
16. [A clinical study of bladder stone with spinal cord injury in subacute stage]. M Nagashima T Taziri K Tanaka, Hinyokika Kiyo 2008 54 647 650 19048928
17. Towards a catheter free status in neurogenic bladder dysfunction: a review of bladder management options in spinal cord injury (SCI). F Jamil, Spinal Cord 2001 39 355 361 10.1038/sj.sc.3101132 11464308
18. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. K Pahan FG Sheikh AM Namboodiri I Singh, J clin invest 1997 100 2671 2679 10.1172/JCI119812 9389730
19. Statins and demyelination. M Weber SS Zamvil, Curr Opin Neurol 2008 318 313 324
20. Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy. N Nath S Giri R Prasad A Singh I Singh, j immunol 2004 172 1273 1286 14707106
21. Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin. R Stanislaus P K AK Singh I Singh, neurosci Lett 1999 269 71 74 10.1016/S0304-3940(99)00414-0 10430507
22. Combined medication of lovastatin with rolipram suppresses severity of experimental autoimmune encephalomyelitis. A Paintlia P Mk I Singh AK Singh, Exp Neurol 2008 214 168 180 10.1016/j.expneurol.2008.07.024 18775426
23. Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study. VG Athyros DP Mikhailidis EN Liberopoulos AI Kakafika A Karagiannis AA Papageorgiou K Tziomalos ES Ganotakis M Elisaf, Nephrol Dial Transplant 2007 22 118 127 10.1093/ndt/gfl538 16998214
24. Atorvastatin inhibits renal crystal retention in a rat stone forming model. M Tsujihata C Momohara I Yoshioka A Tsujimura N Nonomura A Okuyama, J Urol 2008 180 2212 2217 10.1016/j.juro.2008.07.024 18804815
25. Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability. MS Zhou IH Schuman EA Jaimes L Raij, Am J Physiol Renal Physiol 2008 295 53 59 10.1152/ajprenal.00041.2008 18463318
26. Simvastatin reverses high glucose-induced apoptosis of mesangial cells via modulation of Wnt signaling pathway. CL Lin H Cheng CW Tung WJ Huang PJ Chang JT Yang JY Wang, Am J Nephrol 2008 28 290 297 10.1159/000111142 18004065
27. Cytokine dysregulation in chronic kidney disease: how can we treat it? J Carrero Y Mi L B P Stenvinkel, blood purif 2008 26 291 299 10.1159/000126926 18421214
28. Post-trauma Lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection, and promotes locomotor recovery following spinal cord injury. R Pannu DK Christie E Barbosa I Singh AK Singh, J Neurochem 2007 101 182 200 10.1111/j.1471-4159.2006.04354.x 17217414
29. Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats. R Pannu E Barbosa AK Singh I Singh, J Neurosci Res 2005 79 340 350 10.1002/jnr.20345 15605375
30. A new device for experimental modeling of central nervous system injuries. M Bilgen, Neurorehabil Neural Repair 2005 19 219 226 10.1177/1545968305278635 16093412
31. A sensitive and reliable locomotor rating scale for open field testing in rats. MS Basso M Beattie JC Bresnahan, J Neurotrauma 1995 12 1 27 10.1089/neu.1995.12.1 7783230
32. Interactions between mast cells and nerves. Neurogenic inflammation. J Kiernan, Trends Pharmacol Sci 1990 11 316 10.1016/0165-6147(90)90233-X 2392808
33. Long term evaluation of functional and morphological bladder alterations on alloxan-induced diabetes and aging: experimental study in rats. A Rodrigues H Suaid S Tucci V Fazan M Foss A Cologna AC Martins, acta cir bras 2008 23 53 58 18516449
34. Intracellular calcium in hypertrophic smooth muscle from rat urinary bladder. A Arner R Sjuve Scott H Haase I Morano B Uvelius, Scand J Urol Nephrol 2007 41 270 277 10.1080/00365590701225970 17763216
35. Urinary retention in women. CJ Fowler, BJU Int 2003 91 463 464 10.1046/j.1464-410X.2003.04141.x 12656891
36. Characterization of acute renal failure in the burned patient. M Planas T Wachtel H Frank LW Henderson, Arch Intern Med 1982 142 2087 2091 10.1001/archinte.142.12.2087 7138158
37. Correlation of specific gravity and osmolality of urine in neonates and adults. S Leech MD Penney, Arch Dis Child 1987 62 671 673 10.1136/adc.62.7.671 3632012
38. Inner medullary collecting duct function in ischemic acute renal failure. DR Wilson U Honrath, Clin Invest Med 1988 11 157 166 3402104
39. Low urine osmolarity as a determinant of cisplatin-induced nephrotoxicity. E Polycarpe L Arnould E Schmitt L Duvillard E Ferrant N Isambert C Duvillard JL Beltramo D Chevet B Chauffert, Int J Cancer 2004 111 131 137 10.1002/ijc.20202 15185354
40. Use of a first-line urine protein-to-creatinine ratio strip test on random urines to rule out proteinuria in patients with chronic kidney disease. M Guy R Newall B J K Pa C Price, nephrol dial transplant 2009 24 1189 1193 10.1093/ndt/gfn612 18987264
41. Effect of cerivastatin on proteinuria and urinary podocytes in patients with chronic glomerulonephritis. T Nakamura C Ushiyama K Hirokawa S Osada T Inoue N Shimada H Koide, nephrol dial transplant 2002 17 798 802 10.1093/ndt/17.5.798 11981066
42. Effects of statins on renal function. R Agarwal, Am j cardiol 2006 97 748 755 10.1016/j.amjcard.2005.09.110 16490450
43. Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy. M Buemi A Allegra F Corica C Aloisi M Giacobbe G Pettinato A Corsonello M Senatore N Frisina, clin parmacol ther 2000 67 427 431 10.1067/mcp.2000.105330
44. The effect of lovastatin on proliferation of cultured rat mesangial and aortic smooth muscle cells. K Choi SW Kang SW Lee HY Lee DS Han BS Kang, Yonsei Med J 1995 36 251 261 7660676
45. Nitric oxide-mediated suppression of detrusor overactivity by arginase inhibitor in rats with chronic spinal cord injury. K Sasatomi S Hiragata M Miyazato MB Chancellor SM Morris Jr N Yoshimura, Urology 2008 72 696 700 10.1016/j.urology.2007.12.002 18358516
46. Changes in renal medullary transport proteins during uncontrolled diabetes mellitus in rats. D Kim JM Sands JD Klein, Am J Physiol Renal Physiol 2003 285 303 309 12697581
47. Effects of the renal medullary pH and ionic environment on vasopressin binding and signaling. E Zalyapin R Bouley U Hasler J Vilardaga H Lin DR Brown DA Ausiello, kidney int 2008 74 1557 1567 10.1038/ki.2008.412 18813286
48. The bladder epithelium and overactive bladder: what we know. CK Moore HB Goldman, Curr Urol Rep 2006 7 447 449 10.1007/s11934-006-0052-7 17052439
49. An active renal crystal clearance mechanism in rat and man. B Vervaet t Verhuls S Dauwe M De Broe PC D'Haese, kidney int 2009 75 41 51 10.1038/ki.2008.450 18784645
50. Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. SR Khan, Urol Res 2005 33 349 357 10.1007/s00240-005-0492-4 16292585
51. Impaired peroxisomal function in the central nervous system with inflammatory disease of experimental autoimmune encephalomyelitis animals and protection by lovastatin treatment. I Singh P As K M Stanislaus MK Paintlia E Haq AK Singh MA Contreras, Brain Res 2004 1022 1 11 10.1016/j.brainres.2004.06. 059 15353207
52. Rosuvastatin protects against podocyte apoptosis in vitro. A Cormack PT Brinkkoetter JW Pippin SJ Shankland RV Durvasula, nephrol dial transplant 2009 24 404 412 10.1093/ndt/gfn528 18820279
53. Clinical pharmacokinetics of atorvastatin. H Lennernas, Clin Pharmacokinet 2003 42 1141 1160 10.2165/00003088-200342130-00005 14531725
54. Effects of the flavonol quercetin on the bioavailability of simvastatin in pigs. R Cermak S Wein S Wolffram P Langguth, Eur J Pharm Sci 2009 38 519 524 10.1016/j.ejps.2009.09.018 19804821
55. Atorvastatin prevents early apoptosis after thoracic spinal cord contusion injury and promotes locomotion recovery. MA Dery G Rousseau M Benderdour E Beaumont, Neurosci Lett 2009 453 73 76 10.1016/j.neulet.2009.01.062 19429019
56. Long-term benefits after treatment of traumatic brain injury with simvastatin in rats. A Mahmood A Goussev H Kazmi C Qu D Lu M Chopp, Neurosurgery 2009 65 187 191 discussion 191-182 10.1227/01.NEU.0000343540.24780.D6 19574841
57. Lack of robust neurologic benefits with simvastatin or atorvastatin treatment after acute thoracic spinal cord contusion injury. CM Mann JH Lee J Hillyer AM Stammers W Tetzlaff BK Kwon, Exp Neurol 2010 221 285 295 10.1016/j.expneurol.2009.11.006 19931252
58. Muscarinic receptor subtypes and receptor-coupled phosphatidylinositol hydrolysis in rat bladder smooth muscle. H Mimata Y Nomura A Emoto J Latifpour M Wheeler RM Weiss, Int J Urol 1997 4 591 596 10.1111/j.1442-2042.1997.tb00315.x 9477190
59. Role of tyrosine phosphorylation of phospholipase C gamma1 in the signaling pathway of HMG-CoA reductase inhibitor-induced cell death of L6 myoblasts. T Mutoh T Kumano H Nakagawa M Kuriyama, FEBS Lett 1999 446 91 94 10.1016/S0014-5793(99)00188-X 10100621
60. M2 receptors in genito-urinary smooth muscle pathology. A Braverman J Legos W Young G Luthin M Ruggieri, Life Sci 1999 64 429 436 10.1016/S0024- 3205(98)00582-7 10069506
61. Influence of glutamate receptor antagonists on micturition in rats with spinal cord injury. M Yoshiyama FM Nezu O Yokoyama MB Chancellor WC de Groat, Exp Neurol 1999 159 250 257 10.1006/exnr.1999.7124 10486193
62. Bladder overactivity and hyperexcitability of bladder afferent neurons after intrathecal delivery of nerve growth factor in rats. N Yoshimura NE Bennett Y Hayashi T Ogawa O Nishizawa MB Chancellor WC de Groat S Seki, J Neurosci 2006 26 10847 10855 10.1523/JNEUROSCI.3023-06.2006 17050722
63. Role of transforming growth factor beta in rat bladder smooth muscle cell proliferation. MM Barendrecht AC Mulders H van der Poel MJ van den Hoff M Schmidt MC Michel, J Pharmacol Exp Ther 2007 322 117 122 10.1124/jpet.106.119115 17435108
64. Deletion of SM-B, the high ATPase isoform of myosin, upregulates the PKC-mediated signal transduction pathway in murine urinary bladder smooth muscle. J Hypolite S Chang E LaBelle G Babu M Periasamy A Wein S Chacko, am J Physiol Renal Physiol 2009 296 658 665 10.1152/ajprenal.90221.2008